NCT03179605View on ClinicalTrials.gov

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

PHASE2TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

June 3, 2019

Study Completion Date

June 3, 2020

Conditions
Psoriasis
Interventions
DRUG

DFD06

Apply twice per day for 15 days

Trial Locations (9)

29607

Site 106, Greenville

33010

Investigational Site 102, Hialeah

33012

Site 109, Hialeah

63141

Site 103, St Louis

66215

Site 107, Overland Park

68522

Investigational Site 101, Lincoln

92705

Site 108, Santa Ana

93637

Site 104, Madera

99203

Site 105, Spokane

Sponsors
All Listed Sponsors
collaborator

Prosoft Clinical

OTHER

lead

Primus Pharmaceuticals

INDUSTRY